The Victorian Government has supported New Zealand medical device remanufacturer Medsalv to set up their manufacturing and R&D facility in Victoria, introducing new sustainable remanufacturing capabilities to the Australian healthcare ecosystem.
The company’s product recycling portfolio includes patient transfer mattresses, deep vein thrombosis prevention sleeves, blood pressure cuffs and tourniquets.
Medsalv addresses the growing demand for eco-friendly healthcare solutions to reduce reliance on overseas products, resulting in a more robust supply chain and positive environmental outcomes.
The new Victorian headquarters will enable Medsalv to collect single-use medical devices from hospitals in Australia and remanufacture them for safe use in a process that involves cleaning, testing, inspecting, packaging and relabelling of products to prevent them from going into landfill.
Around 50 jobs will be created over five years, including opportunities for disadvantaged groups.
By securing Medsalv’s advanced manufacturing presence in Victoria, the state is poised to reap the benefits of exports to potential markets in Fiji, Singapore, Brazil, the UK and other parts of Europe.
The facility will also enable collaboration with research institutions and universities in Victoria, harnessing our strong R&D ecosystem and boosting our standing as a leader in medtech manufacturing and innovation.
Victoria is the leading Australian investment destination for advanced manufacturing projects, attracting $588 million in foreign direct investment last financial year that created more than 2,500 new jobs.
Learn about the Victorian digital health sector and its investment opportunities.
